Myostatin as a plausible biomarker for early stage of sarcopenic obesity

Abstract Since sarcopenic obesity (SO) impacts negatively on our health, early detection of SO is essential. However, prevalence of SO in an apparently healthy population has not been well examined. This study aimed to elucidate the prevalence and related factors of SO in middle-aged women, and to i...

Full description

Bibliographic Details
Published in:Scientific Reports
Main Authors: Chisaki Ishibashi, Kaori Nakanishi, Makoto Nishida, Haruki Shinomiya, Maki Shinzawa, Daisuke Kanayama, Ryohei Yamamoto, Takashi Kudo, Izumi Nagatomo, Keiko Yamauchi-Takihara
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Subjects:
Myostatin
Sarcopenia
Obesity
Metabolic diseases
Online Access:https://doi.org/10.1038/s41598-024-79534-5

Internet

https://doi.org/10.1038/s41598-024-79534-5

Similar Items